Progesteron’s agonist Dydrogesteron in the treatment of the miscarriage

M. A. Repina; Репина М. А.; N. E. Lebedeva; Лебедева Н. Е.; L. P. Zdanuk; Жданюк Л. П.; A. V. Ivanova; Иванова А. В.

doi:10.17816/JOWD88936

Progesteron’s agonist Dydrogesteron in the treatment of the miscarriage

作者: Repina M.A.¹^,2, Lebedeva N.E.¹^,2, Zdanuk L.P.¹^,2, Ivanova A.V.¹^,2
隶属关系:
1. Medical Academy of Postgraduate Education
2. City Hospital No.2
期: 卷 49, 编号 1 (2000)
页面: 36-38
栏目: Original study articles
URL: https://bakhtiniada.ru/jowd/article/view/88936
DOI: https://doi.org/10.17816/JOWD88936
ID: 88936

如何引用文章

全文:

详细
全文:
作者简介
参考
补充文件
统计

详细

The study was earned out to investigate effect of Progesterone 's agonist Dydrogesterone in the treatment оf the miscarriage. Thus, it was seen that Dydrogesterone 's treatment (10 mg/daily per os) zvas more effective than Progesterone for prophylactic miscarriage.